- Home
- RILYP vs SRPT Comparison
RILYP vs SRPT Comparison
Compare RILYP & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RILYP
- SRPT
- Stock Information
- Founded
- RILYP 1973
- SRPT 1980
- Country
- RILYP United States
- SRPT United States
- Employees
- RILYP N/A
- SRPT N/A
- Industry
- RILYP Investment Managers
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- RILYP Finance
- SRPT Health Care
- Exchange
- RILYP Nasdaq
- SRPT Nasdaq
- Market Cap
- RILYP N/A
- SRPT 1.7B
- IPO Year
- RILYP N/A
- SRPT 1997
- Fundamental
- Price
- RILYP $2.79
- SRPT $19.08
- Analyst Decision
- RILYP
- SRPT Buy
- Analyst Count
- RILYP 0
- SRPT 25
- Target Price
- RILYP N/A
- SRPT $64.00
- AVG Volume (30 Days)
- RILYP 21.7K
- SRPT 8.0M
- Earning Date
- RILYP 01-01-0001
- SRPT 08-06-2025
- Dividend Yield
- RILYP 30.69%
- SRPT N/A
- EPS Growth
- RILYP N/A
- SRPT N/A
- EPS
- RILYP N/A
- SRPT N/A
- Revenue
- RILYP $854,383,000.00
- SRPT $2,233,371,000.00
- Revenue This Year
- RILYP N/A
- SRPT $26.87
- Revenue Next Year
- RILYP N/A
- SRPT $3.15
- P/E Ratio
- RILYP N/A
- SRPT N/A
- Revenue Growth
- RILYP N/A
- SRPT 59.15
- 52 Week Low
- RILYP $1.73
- SRPT $16.88
- 52 Week High
- RILYP $20.00
- SRPT $154.90
- Technical
- Relative Strength Index (RSI)
- RILYP 64.13
- SRPT 29.98
- Support Level
- RILYP $2.02
- SRPT $17.31
- Resistance Level
- RILYP $2.27
- SRPT $18.64
- Average True Range (ATR)
- RILYP 0.28
- SRPT 1.10
- MACD
- RILYP 0.11
- SRPT 0.70
- Stochastic Oscillator
- RILYP 73.61
- SRPT 44.66
About RILYP B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.